Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPN

Clinical trial NCT05133947 · COMPLETED

Trial details

NCT number: NCT05133947
Sponsor: Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Peripheral Nervous System Diseases

Start date: 2021-10-12
Primary completion: 2022-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.